Actively Recruiting
A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
Led by Qilu Pharmaceutical Co., Ltd. · Updated on 2026-04-07
149
Participants Needed
1
Research Sites
186 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the safety and efficacy of QLP2117 in combination with QL2107 in Advanced Solid Tumor Patients.
CONDITIONS
Official Title
A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histological or cytological confirmation of recurrent or refractory advanced solid tumors, progressed on or intolerable for standard therapy, or no available standard therapy
- At least one measurable disease per RECIST v1.1 for expansion cohorts (phase Iba dose escalation requires at least one assessable lesion)
- Eastern Cooperative Oncology Group Performance Status of 0 or 1
- Agree to provide archived tumor tissue samples of primary or metastatic lesions
- Adequate organ function as described in the protocol
You will not qualify if you...
- Women who are pregnant or breastfeeding
- Positive for HBsAg/HBcAb with HBV-DNA >1000 copy/mL or positive for HCV-Ab with viral replication
- Currently participating in another study and receiving study medication within 4 weeks prior to the first dose
- Active autoimmune disease requiring systemic treatment in the past 2 years
- Active infection requiring systemic therapy
- Received a live vaccine within 30 days before planned start of study treatment
- Known history or evidence of interstitial lung disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Actively Recruiting
Research Team
R
Ruihua Xu, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here